Epigallocatechin Gallate-Modified Silver Nanoparticles Show Antiviral Activity against Herpes Simplex Type 1 and 2
Viruses · 2023
DOI: 10.3390/v15102024 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Malgorzata Krzyzowska und 8 weiteren Autor:innen. Beteiligte Einrichtung: Military Institute of Hygiene and Epidemiology, Kozielska 4, 01-163 Warsaw, Poland. Hauptthemen laut MEDLINE: Metal Nanoparticles, Herpes Simplex, Herpes Genitalis, Herpesvirus 1, Human. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Polish National Science Centre.
Abstract (Originalsprache)
(1)
Background
Epigallocatechin gallate (EGCG) has been recognized as a flavonoid showing antiviral activity against various types of DNA and RNA viruses. In this work, we tested if EGCG-modified silver nanoparticles (EGCG-AgNPs) can become novel microbicides with additional adjuvant properties to treat herpes infections. (2)
Methods
The anti-HSV and cytotoxic activities of EGCG-AgNPs were tested in human HaCaT and VK-2-E6/E7 keratinocytes. HSV-1/2 titers and immune responses after treatment with EGCG-AgNPs were tested in murine models of intranasal HSV-1 infection and genital HSV-2 infection. (3)
Results
EGCG-AgNPs inhibited attachment and entry of HSV-1 and HSV-2 in human HaCaT and VK-2-E6/E7 keratinocytes much better than EGCG at the same concentration. Infected mice treated intranasally (HSV-1) or intravaginally (HSV-2) with EGCG-AgNPs showed lower virus titers in comparison to treatment with EGCG alone. After EGCG-AgNPs treatment, mucosal tissues showed a significant infiltration in dendritic cells and monocytes in comparison to NaCl-treated group, followed by significantly better infiltration of CD8+ T cells, NK cells and increased expression of IFN-α, IFN-γ, CXCL9 and CXCL10. (4)
Conclusions
Our findings show that EGCG-AgNPs can become an effective novel antiviral microbicide with adjuvant properties to be applied upon the mucosal tissues.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Military Institute of Hygiene and Epidemiology, Kozielska 4, 01-163 Warsaw, Poland.
- Division of Microbiology, Department of Preclinical Sciences, Institute of Veterinary Medicine, Warsaw University of Life Sciences, 02-786 Warsaw, Poland.
- Department of Materials Technology and Chemistry, Faculty of Chemistry, University of Lodz, Pomorska 163 St., 90-236 Lodz, Poland.
ORCID-Profile: Katarzyna Ranoszek-Soliwoda, Grzegorz Celichowski
Förderung
- Polish National Science Centre
Zitieren
APA
Krzyzowska, M., Janicka, M., Chodkowski, M., Patrycy, M., Obuch-Woszczatyńska, O., Tomaszewska, E., Ranoszek-Soliwoda, K., Celichowski, G., & Grobelny, J. (2023). Epigallocatechin Gallate-Modified Silver Nanoparticles Show Antiviral Activity against Herpes Simplex Type 1 and 2. Viruses. https://doi.org/10.3390/v15102024
Vancouver
Krzyzowska M, Janicka M, Chodkowski M, Patrycy M, Obuch-Woszczatyńska O, Tomaszewska E, et al. Epigallocatechin Gallate-Modified Silver Nanoparticles Show Antiviral Activity against Herpes Simplex Type 1 and 2. Viruses. 2023. doi:10.3390/v15102024
BibTeX
@article{Krzyzowska2023,
author = {Krzyzowska, Malgorzata and Janicka, Martyna and Chodkowski, Marcin and Patrycy, Magdalena and Obuch-Woszczatyńska, Oliwia and Tomaszewska, Emilia and Ranoszek-Soliwoda, Katarzyna and Celichowski, Grzegorz and Grobelny, Jaroslaw},
title = {Epigallocatechin Gallate-Modified Silver Nanoparticles Show Antiviral Activity against Herpes Simplex Type 1 and 2},
journal = {Viruses},
year = {2023},
doi = {10.3390/v15102024}
}
EUVIMED